Equinix (EQIX)
NASDAQReal EstateReit - SpecialtySnapshot 2026-09-04
$1035.98-0.47%
Close 2026-09-04 · 1-day change
NASDAQReal EstateReit - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · EQIX
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 7 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $1,036 EQIX trades at 28× p/ffo — 2.1× the 13× p/ffo peer median. The market is re-rating it beyond its own range; our $872 fair value is low-confidence here. Analysts target $1,130–$1,400. Note: our $872 fair value sits below the entire analyst range ($1,130–$1,400). Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $1265.00 | — | — | Analyst | medium |
| graham number | 12M | $275.16 | — | — | TTM | medium |
| Peer P/FFO | 12M | $495.50 | 13.2 | 37.54 | TTM | medium |
| Peer P/S | 12M | $378.75 | 3.8 | 98.90 | TTM | medium |
| residual income |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$1130.00 – $1400.00 (median $1265.00) · 11 analysts · as of 2026-08-18
No fragility gates fired.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Cheaper than its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| 12M |
| $189.61 |
| — |
| — |
| TTM |
| medium |
| Own P/E history | 12M | $1610.14 | 69.4 | 23.21 | TTM | medium |
| triangulated | 12M | $323.08 | 13.2 | 24.48 | Triangulated | medium |
| Peer P/FFO | 3Y | $711.50 | 13.2 | 53.91 | Hist. CAGR(prov.) | medium |
| Peer P/S | 3Y | $473.88 | 3.8 | 123.75 | guidance | medium |
| Own P/E history | 3Y | $1003.94 | 69.4 | 14.47 | Analyst | medium |
| Peer P/FFO | 5Y | $905.58 | 13.2 | 68.62 | Hist. CAGR(prov.) | high |
| Peer P/S | 5Y | $517.36 | 3.8 | 135.10 | guidance | high |
| Own P/E history | 5Y | $732.72 | 69.4 | 10.56 | Analyst | high |